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Bacterial parasites that can survive and multiply intracellularly are notable 
for their ability to induce delayed-type hypersensitivity and a concomitant state 
of resistance that is expressed in the enhanced capacity of macrophages to kill 
ingested  organisms  (1).  The mechanism by which macrophages become acti- 
vated in this respect has not been determined, but the process clearly involves 
an activity of specifically sensitized lymphocytes. These are formed in the in- 
fected animal and can be detected by their ability to protect recipients against 
the homologous parasite. 
Cells that can protect normal rats against a challenge infection with Listeria 
monocylogenes  (2)  or  Mycobacterium  tuberculosis  (Lefford,  McGregor,  and 
Mackaness, unpublished data)  are delivered to the thoracic duct of donors in- 
fected with these organisms. The appearance of protective cells in the 15mph of 
Lisleria-infected subjects coincides with the influx of many newly formed lym- 
phocytes: large, medium, and small (2). If the protective cells belong to a rapidly 
proliferating cell population, as the foregoing observation suggests, they should 
be vulnerable to agents that inhibit cell replication. Support for this notion was 
obtained  in  the  current  investigation  in  which  the  plant  alkaloid vinblastine 
sulfate (Vbl) ~  was used to analyze the part played by dividing and nondividing 
lymphocytes in the transfer of cellular resistance to infection. 
It will be shown that a single injection of Vbl given to rats at the peak of their 
response to a primary infection with L. monocytogenes deletes specifically sensi- 
tized effector cells  from the thoracic duct and from an inflammatory exudate 
induced in the peritoneal cavity. The results point to dividing (large)  lympho- 
cytes as the specific mediators of host resistance to L. monocytogenes and provide 
a plausible explanation for their rapid turnover and short circulating life-span 
(2). 
* Supported by the Jacob C. Korb Memorial grant for Cancer Research from the American 
Cancer Society and grant AI 08642 from the National Institute  of Allergy and Infectious 
Diseases. 
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1  Abbreviations used in this paper: BSS, Hanks' balanced salt solution containing 1% fetal 
calf serum; Cy, cyclophosphamide;  PEC, peritoneal exudate cells; T cells, thymus-derived 
lymphocytes; TDL, thoracic duct lymphocytes;  Vbl, vinblastine. 
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Materials and Methods 
Rats.--Male and female (Lewis X  DA)F1 hybrid rats were used. Cell donors weighed 160- 
250 g;  the recipients in which the microbicidal assays were performed weighed 60-90 g. In 
one  experiment, thoracic duct lymphocytes from  Lewis  donors were  transferred  to  female 
recipients belonging to the  (Lewis  X  BN)F1  hybrid cross.  The latter weighed  60-80 g  at 
the beginning of the experiment. 
Microorganisms.--L.  monocytogenes, strain EGD, was used for immunization and challenge. 
Suspensions of the organisms usually were prepared from trypticase soy broth cultures of in- 
fected mouse spleen. In some experiments, however, the organism was reconstituted from a 
standard culture maintained in liquid nitrogen (3). 
Immunization  of Rats and Assay of A ntimlcrobiaI Resistance.--Rats were immunized against 
L. monocytogenes by injecting the organisms subcutaneously into both hind feet, the base of 
the tail, and over the lower abdomen. The total injection volume of 0.6 ml contained approx- 
imately 107 viable units. Protective immunity engendered by this procedure, or by an injection 
of lymphoid cells from specifically immunized donors, was measured in terms of the number 
of viable bacteria present in the liver and spleen at intervals after intravenous challenge with 
8.5  )< 105-2.5  )< 106 living Listeria  (2). In some experiments, rats were given a single subcu- 
taneous injection of cyclophosphamide (Cy  2) (200 mg/kg) 24 h  before adoptive immunization 
and challenge. This large dose not only inhibited the recipients' immune response but also 
amplified the immunity afforded by cells from actively immunized donors. 
Vinblastine.Z--Vbl  was dissolved in 0.85% sodium chloride and injected intravenously in a 
single dose equivalent to 5 #g/g of body weight. 
Preparation of Cell Suspensions.--Thoracic  duct lymphocytes (TDL) were obtained from 
freshly incannulated rats during the first 12 h of lymph drainage. The cells were pooled with 
those from donors belonging to the same group. They were then washed once in Hanks' bal- 
anced salt solution containing 1% fetal calf serum  (BSS) and resuspended in BSS or tissue 
culture medium  199  (Microbiological Associates,  Inc.,  Bethesda,  Md.)  at  a  concentration 
suitable for labeling or injection. 
Peritoneal exudates were harvested 24 h  after a  local injection of 50 #g of alcohol-killed 
L. monocytogenes. The technique for obtaining the cells and the cellular composition of the 
exudates have been described elsewhere (4). 
Radioactive Labeling of Lymphocytes.--TDL were labeled in vivo by injecting prospective 
donors  repeatedly with  [3H]thymidine  (3  Ci/mmol,  New  England  Nuclear  Corp.,  Boston, 
Mass.). The nucleoside was injected subcutaneously approximately every 8 h in a dose equiv- 
alent to 0.34 #Ci/g of body weight. An inoculum in which large lymphocytes and a few me- 
dium lymphocytes alone were labeled was prepared by incubating TDL in vitro in medium 
199 containing 5% fetal calf serum, 1 U of heparin/ml, and [3H]thymidine at a final concen- 
tration of 0.2/~Ci/ml. The mixture was incubated for 1 h at 37°C in a water bath oscillating 
at 120 epm. 
Transfer of Labded Cells.--Labeled  TDL were washed twice in BSS and resuspended in 
1-2 ml of fresh medium for intravenous injection into unlabeled recipients. In order to mini- 
mize reutilization of radioactive residues, individual recipients were housed in a  restraining 
cage (5), where they received a continuous intravenous infusion of Ringer's solution contain- 
ing nonradioactive thymidlne at the rate of 1.2 mg daily. The infusion began several hours 
before cell transfer and was continued to the end of the experiment. 
Autoradiography.--Methanol-fixed  smears of TDL or peritoneal exudate cells (PEC) were 
extracted for 20 min at 4°C with two changes of 5% TCA, then washed for at least 1 h in cold 
2 Cyclophosphamide (Cytoxan) was generously supplied by Mead Johnson & Co., Evans- 
ville, Ind. 
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running water. They were subsequently coated with a 2:1 dilution of K-5 nuclear emulsion 
(Ilford, Ltd., Ilford,  England)  and exposed for 5-7  wk. Autoradiographs  prepared  in this 
manner were stained after development with May-Grtinwald-Giemsa stain. 
RESULTS 
Effect  of Vbl on Specifically  Sensitized Lymphocytes.--Cells that can protect 
recipient rats against a challenge infection with L. monocytogenes appear within 
72 h  in the thoracic duct of rats infected with  this organism. The delivery of 
protective cells to the lymph coincides with  the influx of many newly formed 
cells (2), and it is among these that we should look for the mediators of cellular 
resistance to infection. 
The possibility that the protective cells belong to a  dividing cell population 
was tested  by injecting  5  /zg/g of body weight of Vbl into 6-day Listeria-in- 
fected rats.  Immediately  thereafter  the  thoracic  duct was  incannulated,  and 
cells issuing from the fistula during the first 12 h of lymph drainage were trans- 
ferred intravenously into Cy-treated recipients.  The cells, in a dose equivalent 
to 2  X  106/g of body weight,  were injected  1 h  after the  recipients had been 
challenged intravenously with 9.4 X  105 L. monocytogenes. 
Fig.  1 shows that lymphocytes from Vbl-treated  animals were less effective 
than those from similarly infected but untreated donors in their ability to con- 
tain the challenge infection in the livers and spleens of recipient rats. The results 
imply that large lymphocytes are the principal effector cells responsible for me- 
diating host resistance to L. monocytogenes, because they alone incorporate [SH]- 
thymidine into nuclear DNA and are thus subject to the inhibitory effects of 
the drug. 
Although Vbl deafly inhibited the great majority of sensitized lymphocytes 
in the thoracic duct of Listeria-infected donors, it failed to erase their protective 
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FIG. 1, Curves describing the growth of L. monocytogenes in the livers and spleens of Cy- 
treated  rats infected with 9.7 X  105 living organisms. The animals were nonimmunized con- 
trols  (0--0)  or rats immunized adoptively with 2 X  10  ¢ TDL/g of body weight. These 
were obtained  from either  6-day Listeria-infected donors  (O--O)  or similarly infected 
donors given Vbl (A--A).  Means of 5 4- SD. D.  D.  McGREGOR AND  PAMELA S.  LOGIE  663 
function  entirely.  Fig.  1 indicates  that  recipients  of lymphocytes from Vbl- 
treated donors enjoyed a low but significant level of immunity 48 h after chal- 
lenge.  Apparently,  the lymph of Listeria-infected  rats contains  some Vbl-re- 
sistant cells,  or else those that are vulnerable to the drug continue to function 
for a time in their adopted hosts. The latter possibility was tested by allowing 
lymphocytes from infected donors to reside in recipient rats for 24 h before chal- 
lenging the animals with L. monocytogenes. In the interval between cell transfer 
and challenge, virtually all donor large lymphocytes would be expected to reach 
metaphase, the point at which they are inhibited by Vbl  (6,  7).  Normal rats, 
rather than  Cy-treated animals, were employed as recipients.  These were in- 
jected intravenously with TDL from 6-day Listeria-infected donors to some of 
which  Vbl  had  been  given  immediately before  incannulation.  In  each  case, 
2 X  106 cells/g of body weight were transferred either 24 h  before or 1 h after 
the recipients were challenged with approximately 106 L. monocytogenes. 
Table I shows that Vbl had a severe impact upon the immunity conveyed by 
the donor cells.  It is evident, nonetheless,  that lymphocytes from Vbl-treated 
donors afforded a  significant  (P  <  0.05)  level of protection that remained in 
force for at least 24 h. The cells that convey this protection have not been iden- 
tified  morphologically; however,  their  resistance  to  Vbl  and  their  ability  to 
function for at least 24 h after transfer suggest that they are small lymphocytes. 
Presumably, they are mature members of an immunologically committed cell 
line that was established in the donor in response to the immunizing infection. 
Support for this notion was obtained in the following experiments, in which a 
single injection of Vbl was given to prospective lymphocyte donors at various 
intervals after infection. 
Effect  of  Vbl on  the Protective Capacity  of Lymphocytes  Obtained  at  Various 
Intervals after Infection.--Nine separate experiments were undertaken in which 
TABLE I 
Protective Immunity in Recipients of TDL from  Listeria-Infected Rats to Some of Which a 
Single Injection of Vbl ttad Been Given at the Time of Incannulation 
Listeria challenge (relative  Donor treatment  to cell transfer)* 
Log10 protection:~ 
Liver  Spleen 
h 
None  -- 1  2.38  2.25 
Vbl§  0.40  0.48 
None  -1-24  2.53  1.95 
Vbl§  0.94  0.69 
* Cells obtained from 6-day Listeria-infected donors during the first 12 h of lymph drain- 
age were transferred intravenously in a dose equal to 2 N 106 cells/g of body weight. 
Difference in viable Listeria in  tissues of adoptively immunized recipients and  non- 
immunized controls 48 h after challenge. Mean of 5. 
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Vbl was administered  to donor rats 5-15 days after an immunizing Listeria in- 
fection.  In each case  the drug was injected  intravenously immediately before 
incannulation of the thoracic duct. Lymphocytes obtained from these animals, 
or from a  panel  of similarly  infected  but  untreated  donors,  were  transferred 
intravenously into normal recipients I h after the recipients had been challenged 
with approximately 106 L. monocytogenes.  As there was a small but unavoidable 
variation in the number of organisms used for immunization and challenge, the 
results have been expressed in Fig. 2 as the difference in log viable units found 
in the livers and spleens of adoptively immunized rats  and nonimmunized  con- 
trols 48 h  after challenge. 
It is evident that the lymph of 5-day Listeria-infected donors contained pro- 
tective lymphocytes and that these were completely inhibited by Vbl. Vbl-re- 
sistant cells were delivered to the thoracic duct between the 5th and llth days 
of the infection, and with advancing time accounted for an increasing portion 
of the  protective  cell  population.  Beyond the  llth  day,  however,  protective 
cells could no longer be detected in the lymph. The results give credence to the 
notion that the Vbl-resistant lymphocytes are mature members of an immuno- 
logically committed cell line. 
Thelarge dose of Vbl (5 ~g/g) employed in these experiments not only inhibited 
the  great majority of lymphocytes specifically committed to Listeria antigens 
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FIG. 2. Plots depicting the development of a population of specifically sensitized lympho- 
cytes in the thoracic duct of Listeria-infected rats to some of which a single injection of Vbl 
had been given immediately before incannulation.  2  X  106 lymphocytes/g of body weight 
were transferred intravenously into recipient rats 1 h after the recipients had been challenged 
with approximately  106 living organisms. Each plot represents the mean difference in log vi- 
able units in the livers and spleens of five adoptively immunized subjects and five nonimmu- 
nized controls 48 h after challenge. The closed circles denote  the protective  immunity con- 
veyed by lymphocytes from infected donors; the open circles denote the immunity transferred 
by cells from similarly infected donors given Vhl. D.  D.  MCGREGOR  AND  PAMELA  S,  LOGIE  665 
but also caused a reduction in output of cells from the thoracic duct. During the 
first 12 h  of lymph drainage, the mean output from 15 Vbl-treated donors and 
9 untreated subjects was 386 -4- 74 )< 106 and 713 4- 93 )< 106 cells, respectively. 
The low output from Vbl-treated animals and the fact that the great majority 
of cells in central lymph are small lymphocytes impelled us to ask whether these 
nondividing cells were affected by the drug. The problem was examined in the 
following experiment, in which the aggressive behavior of TDL was measured 
in a graft-vs.-host assay. 
Effect of Vbl on the Ability of Lymphocytes to Initiate a Graft-vs.-Host Reaction. 
--Lymphocytes from the thoracic duct of normal adult rats can cause a fatal 
wasting  illness  in  F1  hybrid  recipients  that  have  a  parent  belonging  to  the 
donors' inbred strain. The aggressor cells have been identified as small lympho- 
cytes  (8,  9).  Since  their  capacity  to  induce  a  graft-vs.-host reaction  is  po- 
tentiated by irradiation of the host (10), this procedure was exploited to meas- 
ure the effect of Vbl on the activity of potentially reactive cells.  A  single in- 
jection of the drug was given to each of several normal Lewis rats. Immediately 
thereafter  their  thoracic  ducts  were incanntflated.  Cells  obtained  from these 
animals and from a panel of untreated controls were pooled with cells from the 
same group, and a weight-adjusted dose was injected intravenously into irradi- 
ated recipients belonging to the (Lewis)< BN)F1 hybrid cross. 
The injected  cells were  highly aggressive in  their  adopted hosts.  Table II 
indicates that approximately 10 million donor lymphocytes were lethal for most 
recipients and  that  their ability to cause a  graft-vs.-host reaction was unim- 
paired by treatment of the donors with Vbl. The results buttress the view that 
dividing  (large)  lymphocytes are the targets of Vbl and virtually exclude the 
possibility that lymphocytes are inhibited by the drug regardless of their posi- 
tion in the division cycle. 
TABLE II 
Aggressive Behavior of TDL from Normal Lewis Rats to Some of Which a Single Injection  of 
Vbl Had Been Given at the Time of Incannulation 
Lewis TDL 
Donor treatment  Lymphocytes transferred 
Fate of (Lewis X  BN) F1 hybrid recipients* 
Rats inoculated  Rats ill  Rats killed 
None 
XI~ 4 per g body wt 
15  11  11  11 
10  13  13  12 
5  25  23  17 
Vbl,  15  10  10  10 
10  10  10  9 
* Female rats 60-80 g in body weight were exposed to 350 rad of whole body X and gamma 
irradiation 24 h before lymphocyte transfer. 
3~ 5 #g/g of body weight injected intravenously. 666  MEDIATOR  OF  CELLULAR  IM:~UNITY.  VI 
Effect of Vbl on the Protective Capacity of PFC.--In an earlier study (4) it was 
shown  that  specifically sensitized lymphocytes of  the  kind that  mediate cel- 
lular resistance to infection with L.  monocytogenes  can be recovered in  a  fully 
functional  condition  from  inflammatory  exudates  induced  in  the  peritoneal 
cavity of rats  infected with  this  organism.  If the protective cells  are  mainly 
large  lymphocytes, they  should  be  vulnerable  to  Vbl.  This  proposition  was 
tested by administering a single  dose of Vbl to each of several rats on the 6th 
day of an  immunizing Listeria infection.  Immediately thereafter  the  animals 
were stimulated intraperitoneally with 50 #g of killed Listeria. Peritoneal exu- 
dates harvested 24 h after stimulation were transferred to Cy-treated recipients 
in a dose equivalent to 5 X  105 cells/g of body weight. The cells were injected 
intravenously 1 h  after the recipients had been challenged by the same route 
with 1.15 X  106 L. monocytogenes. 
Fig.  3  indicates  that  a  measure  of protective immunity was conveyed by 
PEC  obtained  from  either  Vbl-treated  donors  or  similarly  infected  but  un- 
treated controls. However, the recipients of cells  from Vbl-treated donors en- 
joyed substantially  less  protection in  both  the  liver  and  spleen.  The  results 
suggest that the effector cells belong to a proliferating lymphocyte population 
similar to that present in the l~anph of infected rats. 
Since  the  specifically sensitized  lymphocytes that  transfer  resistance  to L. 
monocywgenes  are either absent or present in only small numbers in the unin- 
flamed peritoneal cavity (4),  they must be members of a  cell population that 
emerges from the blood in response to inflammation. Autoradiographic studies 
(11)  of the tissue disposition of newly formed lymphocytes obtained from Lis- 
teria-infected  donors  support  this  contention,  and  point  again  to  a  large 
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FIG. 3. Curves describing the growth of L. monocytogenes in the livers and spleens of Cy- 
treated rats infected with 8.5 X  105 living organisms. The animals were nonimmunized con- 
trols (0----0) or rats immunized adoptively with 5 X 105 PEC. The latter were obtained 
from either 7-day Listeria-infected donors (©--O)  or similarly infected donors given Vbl 
(A  A) at the time of exudate induction. Means of 5 ~: SD . D.  D.  McGREGOR  AND  PAMELA  S.  LOGIE  667 
lymphocyte  as  the  principal  cell  type  responsible  for  transferring  resistance 
to this infectious agent. 
Effect of Vbl on the Exudate-Seeking Capacity of Newly Formed L ymphocytes.-- 
Prospective  donors  were  injected  repeatedly  with  [3H]thymidine  during  the 
first  6  days of an  immunizing Listeria  infection.  A  number of these  animals 
were then  given a  single injection  of Vbl immediately before incannulation  of 
the thoracic duct.  Cells issuing from the fistula during the first  12 h  of lymph 
drainage were pooled with cells from animals in the same group, and 3.6  X  108 
were  transferred  intravenously into  each  of several  recipients.  The  recipients 
were  given  a  continuous  infusion  of nonradioactive  thymidine  at  the  rate  of 
1.2 mg daily and, immediately after transfer, were stimulated intraperitoneally 
with  killed  L.  monocytogenes.  Smears  prepared  from samples  of the donor in- 
ocula  and  from cells obtained  from the peritoneal  cavity of individual  recip- 
ients 24 h  after transfer were examined autoradiographically. 
Table  III  indicates  that  the  inoculum  prepared  from Vbl-treated  donors 
contained fewer large and medium lymphocytes, but approximately the same 
number  of labeled  small  lymphocytes,  as  the  "control"  inoculum,  i.e.,  TDL 
obtained from labeled Listeria-infected rats that had not been given Vbl. How- 
ever,  there was a  remarkable difference in the exudate-seeking capacity of the 
labeled  cells.  In  recipients  of cells from Vbl-treated  donors,  only one labeled 
medium lymphocyte and a  few labeled  small  lymphocytes were found among 
the more than 5,000 cells examined from each exudate.  By comparison, a  sub- 
TABLE III 
Effect of Vbl on the Exudate-Seeking Capacity of TDL Labded with [aH]Thymidine in  Vivo* 
Donor treatment 
Labeled lymphocytes transferred 
(XlO  -4  ) 
Lymphocytes in recipient exudate$ 
(X  10  -4) 
Large and medium  Small  Total  Labeled large  Labeled 
and medium  small 
None  1,974  3,484  758  42  50 
901  39  52 
806  45  55 
794  38  57 
964  53  87 
Vbl§  896  3,554  287  1  5 
558  <1  6 
519  < 1  t0 
* Donor rats given  18 injections  of [3H]thymidine during  the first 6 days of a primary 
Listeria infection. 3.6 )<  l0 s cells collected from the thoracic duct during the first 12 h after 
the last  injection  were transferred  intravenously  into each  of several  recipients.  Immedi- 
ately thereafter  the  recipients  were  stimulated  intraperitoneally  with  50  #g  of killed L. 
monocytogenes. 
:~ Harvested 24 h after exudate induction. Autoradiographs exposed for 7 wk. 
§ 5/zg/g of body weight injected intravenously  immediately before incannulation. 668  MEDIATOR OF  CELLULAR IM2ViUNITY. V'f 
stantial  number  of labeled lymphocytes  originally present  in  the  control  in- 
oculum were found in exudates induced in similar recipients. The large number 
of labeled small lymphocytes found in this group suggests that many derived 
from replicating precursors of the kind inhibited by Vbl. Evidence to  support 
this notion was obtained in the following experiment, in which the fate of donor 
large  lymphocytes  was  determined  by  labeling  the  cells with  [~H]thymidine 
in vitro. 
E~ect of Vbl on the Exudate-Seeking Property of Large Lymphocytes.--Inocula 
in  which  large  and medium lymphocytes were  the  only  radioactively labeled 
cells were prepared by incubating TDL  in vitro for  1 h  in medium containing 
[3H]thymidine.  The  donors  in  this  experiment  were  6-day  Listeria-infected 
rats to  some of which  a  single injection of Vbl had geen  given at  the  time of 
incannulation.  Cells issuing from  the  fistulae were  transferred  intravenously 
into syngeneic recipients, the usual precautions being taken to minimize reutili- 
zation of radioactive residues released from labeled donor cells. Each  recipient 
was given 4  X  l0  s cells. Immediately thereafter all were stimulated intraper- 
itoneaUy with killed L.  monocytogenes. PEC  obtained from these animals 24 h 
after stimulation were examined autoradiographically. 
Table IV shows that the lymph of both Vbl-treated donors and their respec- 
tive controls contained labeled large and medium lymphocytes; labeled small 
lymphocytes were not found among the more than 5,000 donor cells examined. 
Only two labeled lymphocytes (both small) were found in recipients of cells from 
Vbl-treated rats. In contrast,  a  moderate number of labeled lymphocytes were 
TABLE  IV 
Effect of Vbl on the Emulate-Seeking Capacity of TDL Labeled with [aH]Thymidine in  Vitro* 
Donor treatment 
Labeled  lymphocytes  transferred 
(X 10 4) 
Lymphocytes  in recipient  exudate; 
(X  to  -4) 
Large and medium  Small  Total  Labeled  large  Labeled  and medium  small 
None  433  <1 
Vbl §  90  < 1 
527  1  8 
849  5  14 
496  7  18 
762  14  28 
407  <1  <1 
602  < 1  < 1 
532  < 1  1 
668  < 1  1 
* Cells obtained from 6-day Listerla-infected donors during the first 12 h of lymph drain- 
age. After in vitro labeling with [3H]thymidine (see  Methods), 4 X  108 cells were  transferred 
intravenously into  each  of  several  recipients.  Immediately thereafter the  recipients  were 
stimulated intlaperitoneally  with 50/zg  of killed L,  monocytogenes. 
:~ Harvested 24 h after exudate induction.  Autoradiographs exposed for 5 wk. 
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found in exudates induced in the four recipients of "control" cells. The labeled 
exudate cells varied in size: some were large lymphocytes, similar to those that 
had  incorporated  [3H]thymidine in vitro; others were typical small  lympho- 
cytes. It is evident, therefore, that some donor large lymphocytes had migrated 
from the  blood into  the  inflamed peritoneal  cavity of the  recipients,  where 
they gave rise to smaller lymphocytes. 
DISCUSSION 
Acquired  resistance  to L.  monocytogenes is mediated by lymphocytes that 
are represented among the free-floating cells in the central lymph of animals 
infected with this organism. Protective cells appear in the thoracic duct within 
72 h of an immunizing infection. Their sudden influx at this time suggests that 
they belong to a  rapidly dividing cell  population. The results of the current 
investigation give credence to this notion, for they indicate that the cells that 
can protect normal rats against  a  Listeria  challenge are highly vulnerable to 
Vbl. 
Vbl is an appropriate drug for studies of this type, because it has a  short 
half-life in vivo (12,  13) and acts selectively upon dividing cells,  causing Ineta- 
phase arrest and cell death (6, 7). In the current investigation, small lympho- 
cytes, which divide infrequently or not at all, were shown to be highly resistant 
to Vbl. Their resistance was revealed in the failure of Vbl to inhibit the aggres- 
sive activity of Lewis TDL in a graft-vs.-host assay (Table II). The ability of 
Vbl-treated cells to transfer immunological memory of the bacteriophase  (I,X- 
174  (McGregor and Mackaness,  unpublished data)  provides further evidence 
to this effect and implies that dividing lymphocytes are selectively destroyed 
by the drug. 
It is to be emphasized that the specifically sensitized lymphocytes that me- 
diate  cellular  resistance  to  L.  monocytogenes do  not  belong  to  a  single, 
homogeneous class.  The present studies using Vbl substantiate this contention 
and suggest that the makeup of the protective cell population changes as the 
response evolves. Vbl has a major impact on the protective function of lym- 
phocytes obtained from the thoracic duct of Listeria-infected  donors, but the 
timing of the drug injection is crucial. Thus, Vbl deletes sensitized lympho- 
cytes from the duct on the 5th day of a primary immunizing infection (Fig. 2). 
Thereafter, Vbl-resistant  cells are added  to the  lymph and  comprise  an  in- 
creasing proportion of the protective cell population. 
The foregoing observations  suggest  that  large  lymphocytes are  immature 
members of a  specifically committed cell line and are the first to be released 
into  the  circulation  of Listeria-infected  rats.  Vbl-resistant  lymphocytes are 
delivered to the blood later in the infection. The latter have not yet been iden- 
tified morphologically, although  it  seems likely that  they are  small lympho- 
cytes. Two lines of evidence support this conclusion: (a)  an injection of Vbl 
has no effect on the proportion of newly formed small lymphocytes delivered 
to the thoracic duct of 6-day Listeria-infected  rats (Table III), and (b) the drug 670  MEDIATOR  OF  CELLULAR  IMMUNITY.  VI 
has  only a  trivial  effect on  the protective capacity of lymph-borne cells ob- 
tained later in the response, when the proportion of large lymphocytes in  the 
lymph has declined to the "normal" value. 
Taken at face value, the results of the current investigation imply that large 
lymphocytes are  the principal,  although probably not  the  exclusive, effector 
cells involved in transmitting immunity to L. rnonocytogenes, at least in the rat. 
It cannot be concluded, however, that large lymphocytes have a predominant 
role  in  host  resistance  to  other  infectious  agents.  Lefford,  McGregor, 
and  Mackaness  (unpublished  data)  found that TDL from rats infected with 
M.  boris  (strain  BCG)  can protect normal  recipients against  a  challenge in- 
fection with either attenuated (R1Rv)  or virulent (H3~Rv) strains of M.  tuber- 
culosis.  Since lymphocytes obtained  from Vbl-treated  donors 4  wk  after in- 
fection also afford protection, it would seem that small lymphocytes have an 
important role in host resistance to this organism. 
Factors peculiar to the host-parasite relationship could explain the rate at 
which  committed lymphocytes are  generated,  the  makeup  of the  protective 
cell population, and the cell susceptibility to Vbl. L. monocytogenes  causes an 
acute infection in rats, as it does in mice (14).  The organisms grow vigorously 
for several days in  the livers and  spleens of intravenously infected subjects. 
Thereafter the bacteria are rapidly destroyed by macrophages that acquire an 
enhanced listericidal capability (14,  15). Since Mycobacteria are more resistant 
to intracellular inactivation (16), it is plausible to think  that they provide a 
more  enduring  immunogenic  stimulus.  The  committed  cell  population  gen- 
erated in response to a BCG infection would therefore be expected to include 
a large proportion of "mature" (nondividing) small lymphocytes. 
In an earlier study (2) it was shown that the cells that transfer resistance to 
L. monocytogenes  have a  short circulating life-span. After intravenous transfer 
into  uninfected  recipients,  protective  donor  lymphocytes fail  to  recirculate 
to the thoracic duct in sufficient numbers to confer protective immunity upon 
a  second panel of normal recipients. Failure of the cells to recirculate readily 
from blood to lymph implies that they arise in stimulated lymphoid tissue in 
the  regional lymphatic bed.  Their precise origin  in  parent  lymph nodes has 
not been determined. It may be significant, however, that the delivery of pro- 
tective cells to the thoracic duct is preceded by the appearance of blast cells 
in the paracortex of nodes draining sites of bacterial implantation  (1). These 
blast cells are morphologically indistinguishable from the large pyroninophilic 
cells that develop from small lymphocytes during graft-vs.-host reactions (8). 
Since they arise in  areas of lymphoid tissue which are normally occupied by 
thymus-derived lymphocytes (T cells)  (17,  18) and through which T  cells con- 
tinuously recirculate (19, 20), it is likely that they, too, are thymus dependent. 
This notion accords with the fact  that  host  resistance  of L.  monocytogenes  is 
cell mediated and that the protective function of lymphoid cells obtained from 
Listeria-infected mice is abrogated by anti-~ serum (21). 
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span of lymphocytes specifically committed to Listeria  antigens sets them in a 
class apart from the majority of lymph-borne cells. The inability of protective 
cells to recirculate from blood to lymph could reflect a  readiness to leave the 
blood in areas of inflammation. It is to be noted in this connection that pro- 
tective cells can be recovered in a fully functional condition from inflammatory 
exudates induced in  the peritoneal cavity of Listeria-infected  rats  (4).  Since 
protective cells are either absent or present in only small numbers in the un- 
stimulated  peritoneal  cavity, they must  belong to  a  mobile population  that 
emerges from the blood in response to inflammation. The results of the present 
investigation substantiate this contention and show, in addition, that a dividing 
(large) lymphocyte is the principal effector cell type present in exudates. There 
can be little doubt that the effect of the drug is on large lymphocytes, for when 
these alone were radioactively labeled before intravenous transfer, labeled cells 
from Vbl-treated donors were rarely found in  peritoneal exudates induced in 
recipient rats. 
The remarkable capacity of large lymphocytes to leave the blood in areas of 
inflammation has  important  implications in infections caused  by facultative 
intracellular  parasites  in  which  host  resistance  rests  ultimately  with 
macrophages (1). Several lines of evidence support the view that host resistance 
to L. monocytagenes depends on the collaborative participation of specifically 
sensitized  lymphocytes  and  mononuclear  phagocytes  (1).  The  requirement 
for macrophages is illustrated in the failure of Listeria-infected  animals to ben- 
efit from an injection of committed lymphocytes when they are unable to as- 
semble  monocyte-derived macrophages  in  an  inflammatory exudate.  This  is 
the case, for example, in mice exposed to a large  dose of whole body X irradi- 
ation (22,  23) and rats given a potentially lethal dose of Cy (24). 
Since lymphocytes from animals infected with L. monocytogenes can confer 
specific  antimicrobial  resistance  upon  uninfected  recipients,  it  seems  likely 
that an important function of these cells is to provide the stimulus required 
to  enhance  macrophage  microbicidal  function.  The  events  underlying  this 
activation process have not been determined, but they could involve the ac- 
tivity of a lymphokine. In fact, it has been reported recently that a product of 
antigen-stimulated  lymphocytes  can  influence  the  microbicidal  capacity  of 
macrophages in vitro (25,  26). 
The propensity of dividing (large) lymphocytes to localize in areas of non- 
specific inflammation  could explain how specific effector cells assemble in in- 
fective foci. It is conceivable that inflammation initiated by the parasite or by 
an  immunologically specific event involving either  cells or  antibody  creates 
circumstances in which dividing lymphocytes, regardless of the immunological 
commitment,  assemble  in  lesions.  Here specifically sensitized  cells might  be 
stimulated by microbial antigens to release products that attract macrophages 
and give them an enhanced microbicidal capability. 
Since small lymphocytes either fail to localize in inflammatory foci (11)  or 672  MEDIATOR OF CELLULAR IMMUNITY. VI 
do so only rarely, they are clearly at a  strategic disadvantage with respect to 
their ability to modify macrophage microbicidal function. It is plausible, how- 
ever, that they serve as vehicles for the carriage of immunological memory, a 
function  they  are known  to  discharge  with  respect  to  conventional  antigens 
(27,  29).  According  to  this notion,  small lymphocytes specifically committed 
to the appropriate microbial antigens would rapidly transform into large lym- 
phocytes upon  reinfection with  the homologous parasite,  thereby arming  the 
host with effector cells that localize preferentially in infected tissue. 
SUM-~ARY 
The  antimitotic  drug  vinblastine  (Vbl)  has  a  profound  impact  upon  the 
specifically sensitized lymphocytes that transfer cellular resistance to Listeria 
monocytogenes.  A  12-h  pulse  of  the  drug  given  to  prospective  donors  during 
the first week of an immunizing Listeria infection inhibits the delivery of pro- 
tective lymphocytes to the thoracic duct and their subsequent movement into 
an inflammatory exudate induced in the peritoneal cavity. The effect of Vbl is 
clearly related to its antimitotic activity, not to an effect on lymphoeytes re- 
gardless of their position in the division cycle. This conclusion was drawn from 
an autoradiographic analysis of cells in the lymph of Vbl-treated rats and from 
failure of the drug to abrogate a known function of small lymphocytes, namely, 
their  ability to initiate  a  graft-vs.-host reaction.  The  results imply that large 
lymphocytes, the rapidly proliferating cells in central lymph, are the principal 
effector cells responsible  for transmitting  resistance  to  L.  monocytogenes  and 
provide a  plausible explanation  for their  rapid  turnover and short circulating 
life-span. 
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